KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Other Accumulated Expenses (2016 - 2025)

Exact Sciences has reported Other Accumulated Expenses over the past 15 years, most recently at $15.2 million for Q4 2025.

  • Quarterly Other Accumulated Expenses fell 59.7% to $15.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.2 million through Dec 2025, down 59.7% year-over-year, with the annual reading at $15.2 million for FY2025, 59.7% down from the prior year.
  • Other Accumulated Expenses was $15.2 million for Q4 2025 at Exact Sciences, up from $14.3 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $50.6 million in Q1 2021 and troughed at $8.8 million in Q1 2023.
  • The 5-year median for Other Accumulated Expenses is $29.5 million (2021), against an average of $26.9 million.
  • Year-over-year, Other Accumulated Expenses skyrocketed 786.78% in 2021 and then plummeted 69.56% in 2023.
  • A 5-year view of Other Accumulated Expenses shows it stood at $31.0 million in 2021, then tumbled by 66.91% to $10.2 million in 2022, then surged by 44.63% to $14.8 million in 2023, then skyrocketed by 154.77% to $37.8 million in 2024, then crashed by 59.7% to $15.2 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Other Accumulated Expenses are $15.2 million (Q4 2025), $14.3 million (Q3 2025), and $16.1 million (Q2 2025).